Retatrutide 5mg Vials: Concentration, Reconstitution and Storage for Research

Search for “retatrutide 5mg” and you will find a range of listings, from single vials to multi-vial bundles. The 5mg configuration is one of the smaller vial sizes, suitable for protocols that need a limited quantity or that use the peptide at higher dilution. Understanding how the 5mg vial works, how the concentration is calculated, and how the reconstituted solution should be stored is essential for laboratory work.

This guide explains what a retatrutide 5mg vial is, how the concentration is calculated after reconstitution, how the vial should be stored and handled, and what documentation to verify before sourcing.

What a retatrutide 5mg vial is

Retatrutide is a synthetic triple agonist that activates the GIP, GLP-1, and glucagon receptors. The discovery literature refers to it as LY3437943. The compound is investigational, meaning it has not been approved by the MHRA, the FDA, or any other regulatory agency for any indication.

A 5mg vial contains 5 milligrams of lyophilised retatrutide powder. The powder is stable for extended periods when stored correctly, but it must be reconstituted with a diluent before laboratory use. The Alta Peptides retatrutide product page lists the available configurations and documentation.

The Phase 2 trial published in the New England Journal of Medicine in 2023 evaluated retatrutide at doses of 1mg, 4mg, 8mg, and 12mg in a clinical setting. The trial reported substantial reductions in body weight at 48 weeks. The 5mg configuration is not a clinical dose but a research vial size that provides flexibility in concentration.

Concentration after reconstitution

The concentration of the reconstituted solution depends on the volume of diluent added. The calculation is the mass of peptide divided by the volume of diluent.

Concentration (mg/mL) = Mass of peptide (mg) / Volume of diluent (mL)

For a 5mg vial, the concentration for common diluent volumes is as follows.

The Alta Peptides reconstitution calculator works out the concentration for any combination of mass and volume.

Reconstitution and handling

The reconstitution process for a 5mg retatrutide vial is the same as for any other lyophilised peptide. The Alta Peptides bacteriostatic water product page lists the available diluent configurations.

The key steps are: calculate the volume of diluent needed, add it slowly down the inside wall of the vial, swirl gently to dissolve the powder, and store the resulting solution correctly. Do not shake the vial, as this can cause foaming and damage the peptide structure.

The Alta Peptides guide to reconstituting peptides provides a step-by-step walkthrough of the process.

Storage after reconstitution

Once reconstituted, the retatrutide solution has a shorter shelf life than the lyophilised powder. The Alta Peptides guide to lyophilised peptide stability explains how temperature and humidity affect the product over time.

The Bachem handling and storage guidelines for peptides explain the temperature ranges that maintain peptide integrity. Reconstituted solutions are typically stored at 2 to 8 degrees Celsius and used within a defined window. Bacteriostatic water extends the shelf life compared with sterile water because it contains a preservative.

The researcher’s verification checklist

1. Lot-specific certificate of analysis

A certificate of analysis (COA) is only meaningful if it corresponds to the exact lot you are buying. The COA should list the lot number, the testing laboratory, the report ID, the date the sample was received, and the date the results were published. The Alta Peptides certificates page collects the reports for all products.

2. Measured content, not just label claim

The label states the nominal mass, but the actual mass in the vial may differ slightly. The COA reports a measured content value that reflects the actual fill. For precise work, use the measured content rather than the label claim.

3. Complete analytical panel

A certificate that lists only “purity: 99%” is incomplete. The useful fields are identity by mass spectrometry, purity by HPLC, measured content, endotoxin, and sterility.

4. Research-use-only boundary

The listing should not publish dosing, administration, or human-use content. A supplier that maintains the boundary consistently is easier to trust than one that publishes human-use content alongside the RUO label.

How Alta Peptides approaches retatrutide documentation

Alta Peptides is a UK-based research peptide supplier that publishes lot-specific documentation for each product configuration. The company also publishes a comparison of retatrutide and tirzepatide that explains the mechanistic differences between the two compounds.

Comparing retatrutide vial sizes

Common questions about retatrutide 5mg vials

What concentration do I get from a 5mg vial?

The concentration depends on the volume of diluent added. With 1ml of diluent, the concentration is 5mg/ml. With 2ml, it is 2.5mg/ml. With 5ml, it is 1mg/ml.

Should I use the label claim or the measured content?

For precise work, use the measured content from the certificate of analysis. The label states the nominal mass, but the actual mass in the vial may differ slightly.

How should I store a reconstituted retatrutide solution?

The GenScript storage guide recommends storing reconstituted peptides at 2 to 8 degrees Celsius and using them within a defined window. Bacteriostatic water extends the shelf life compared with sterile water.

What should a retatrutide COA show?

A complete COA should report identity by mass spectrometry, purity by HPLC with the method stated, measured content or assay value, endotoxin testing, and sterility testing. It should also include the lot number, the testing laboratory’s name, the report ID, and the dates of sample receipt and result reporting.

How do I verify that a COA is real?

Check that the testing laboratory is named and that the report ID can be cross-referenced. Some laboratories publish verification portals where a report ID can be entered to confirm the document’s authenticity.

What should I do if a supplier’s listing makes health claims?

Treat it as a disqualifying signal. Health claims on a research peptide listing are the exact pattern that regulators have cited in enforcement actions.